Spectaire (SPEC) Competitors $0.0003 0.00 (0.00%) As of 09/12/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsTrendsBuy This Stock SPEC vs. TBIO, THMO, HTGMQ, OLITW, PRENW, QSIAW, SMAPW, TT, KEYS, and VLTOShould you be buying Spectaire stock or one of its competitors? The main competitors of Spectaire include Telesis Bio (TBIO), ThermoGenesis (THMO), HTG Molecular Diagnostics (HTGMQ), OmniLit Acquisition (OLITW), Prenetics Global (PRENW), Quantum-Si (QSIAW), SportsMap Tech Acquisition (SMAPW), Trane Technologies (TT), Keysight Technologies (KEYS), and Veralto (VLTO). These companies are all part of the "measuring and control equipment" industry. Spectaire vs. Its Competitors Telesis Bio ThermoGenesis HTG Molecular Diagnostics OmniLit Acquisition Prenetics Global Quantum-Si SportsMap Tech Acquisition Trane Technologies Keysight Technologies Veralto Spectaire (NASDAQ:SPEC) and Telesis Bio (NASDAQ:TBIO) are both small-cap measuring and control equipment companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, valuation, media sentiment, risk, earnings and profitability. Which has higher valuation & earnings, SPEC or TBIO? Spectaire has higher earnings, but lower revenue than Telesis Bio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSpectaireN/AN/A$8.95MN/AN/ATelesis Bio$225.09M0.00-$47.72M-$28.200.00 Is SPEC or TBIO more profitable? Spectaire has a net margin of 0.00% compared to Telesis Bio's net margin of -336.59%. Telesis Bio's return on equity of 0.00% beat Spectaire's return on equity.Company Net Margins Return on Equity Return on Assets SpectaireN/A -81.22% 304.57% Telesis Bio -336.59%N/A -61.89% Does the media prefer SPEC or TBIO? In the previous week, Telesis Bio had 1 more articles in the media than Spectaire. MarketBeat recorded 1 mentions for Telesis Bio and 0 mentions for Spectaire. Spectaire's average media sentiment score of 0.00 beat Telesis Bio's score of -1.00 indicating that Spectaire is being referred to more favorably in the media. Company Overall Sentiment Spectaire Neutral Telesis Bio Negative Which has more volatility & risk, SPEC or TBIO? Spectaire has a beta of -6.38, suggesting that its stock price is 738% less volatile than the S&P 500. Comparatively, Telesis Bio has a beta of 2.73, suggesting that its stock price is 173% more volatile than the S&P 500. Do insiders & institutionals have more ownership in SPEC or TBIO? 26.5% of Spectaire shares are owned by institutional investors. Comparatively, 37.6% of Telesis Bio shares are owned by institutional investors. 25.4% of Spectaire shares are owned by insiders. Comparatively, 24.5% of Telesis Bio shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. SummarySpectaire and Telesis Bio tied by winning 5 of the 10 factors compared between the two stocks. Get Spectaire News Delivered to You Automatically Sign up to receive the latest news and ratings for SPEC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SPEC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip Chart SPEC vs. The Competition Export to ExcelMetricSpectaireMeasuring & controlling devices IndustryComputer SectorNASDAQ ExchangeMarket Cap$6K$34.49M$31.24B$10.14BDividend YieldN/A8.43%3.16%4.60%P/E RatioN/A3.88439.7225.98Price / SalesN/A3.291,747.13180.52Price / CashN/A8.3836.9460.44Price / Book0.001.657.246.29Net Income$8.95M$7.16M$808.32M$271.07M7 Day PerformanceN/A-3.67%3.57%3.87%1 Month PerformanceN/A3.31%4.71%5.49%1 Year PerformanceN/A-11.67%24,377.12%25.86% Spectaire Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SPECSpectaireN/A$0.00flatN/AN/A$6KN/A0.008TBIOTelesis Bio0.2649 of 5 stars$0.01flatN/A-99.9%$22K$225.09M0.00200Short Interest ↑THMOThermoGenesisN/AN/AN/AN/A$1K$9.61M0.0040HTGMQHTG Molecular DiagnosticsN/AN/AN/AN/A$0.00$6.37M0.0090OLITWOmniLit AcquisitionN/A$0.07+4.8%N/AN/A$0.00N/A0.003Gap UpPRENWPrenetics GlobalN/A$0.03+11.2%N/A+132.4%$0.00$41.52M0.001Positive NewsQSIAWQuantum-SiN/A$0.25+16.2%N/A+124.7%$0.00$3.41M0.00150Short Interest ↑Gap UpSMAPWSportsMap Tech AcquisitionN/A$0.03-2.6%N/AN/A$0.00N/A0.00N/AGap DownTTTrane Technologies4.6924 of 5 stars$417.12+1.9%$458.60+9.9%+10.1%$91.10B$19.84B33.0845,000News CoveragePositive NewsHigh Trading VolumeKEYSKeysight Technologies4.4604 of 5 stars$170.26+0.7%$187.38+10.1%+13.7%$29.06B$4.98B54.2215,500Trending NewsAnalyst RevisionVLTOVeralto3.4084 of 5 stars$106.00+0.9%$113.43+7.0%-0.9%$26.06B$5.19B29.6117,000News CoveragePositive News Related Companies and Tools Related Companies TBIO Alternatives THMO Alternatives HTGMQ Alternatives OLITW Alternatives PRENW Alternatives QSIAW Alternatives SMAPW Alternatives TT Alternatives KEYS Alternatives VLTO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SPEC) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored6-Figure Target for BTC by 2025The U.S. just announced it's putting GDP data directly onto Bitcoin and Ethereum blockchains. Could this spa...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone thought he was insane…SpaceX just struck a $17 billion deal with EchoStar for radio frequencies, and tech analyst Jeff Brown says it...Brownstone Research | SponsoredWall Street Legend Issues Urgent AI Stock Warning'Hidden AI' is taking the U.S. stock market by storm.Chaikin Analytics | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredTrump’s new AI budget just passed — one stock could soarIn a quiet move few people noticed... President Trump just green-lit what could become the biggest AI budge...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spectaire Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Spectaire With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
